ND
Nidhi Dubey
About Nidhi Dubey
Data last updated:
Nidhi Dubey has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Vetnosac Research India Private Limited and Agera India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vetnosac Research India Private Limited at ₹3.13 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2022 | 2017 | ₹3.13 Cr (FY 2024) | Active | |
| Director | 29 Aug 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nidhi Dubey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nidhi Dubey
Nidhi Dubey has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Vetnosac Research India Private Limited and Agera India Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vetnosac Research India Private Limited at ₹3.13 Cr (FY 2024).
Nidhi Dubey is associated with 2 companies as Director, including Vetnosac Research India Private Limited (₹3.13 Cr), Agera India Therapeutics Private Limited.
Nidhi Dubey has expertise in General Business.
Nidhi Dubey has 4 years in corporate governance.
By reported revenue, the largest current company of Nidhi Dubey is Vetnosac Research India Private Limited, with revenue of ₹3.13 Cr (FY 2024).
Nidhi Dubey currently holds positions at 2 companies: Vetnosac Research India Private Limited (₹3.13 Cr), Agera India Therapeutics Private Limited.